Development of Catalysts for Asymmetric Synthesis

不对称合成催化剂的开发

• 批准号: 7009556
• 负责人: VIRESH H. RAWAL
• 金额: $ 21.87万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-01-01 至 2007-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7009556
• 关键词: Diels Alder reaction; alcohols; carbonyl group; catalyst; chemical reaction; chemical structure; chemical synthesis; chromium; cobalt; drug design /synthesis /production; electron crystallography; heavy metals; hydrogen bond; stereoisomer; technology /technique development

DESCRIPTION (provided by applicant): The importance of methods for the synthesis of chiral compounds in high enantiomeric purity cannot be overstated. In 2001, single enantiomer drugs comprised 36% ($147 billion) of the total market of $410 billion. This number is projected to increase steadily, such that chiral drugs will constitute a market of over $200 billion by 2008. The growing economic importance of chiral compounds has spurred major research efforts from many laboratories, academic and industrial, directed at the selective preparation of chiral compounds. A recent report from the PI's laboratory described the development of chiral metal-salen complexes that are exceptional catalysts for enantioselective Diels-AIder (DA) reactions, one of the most useful reactions for organic synthesis. A major focus of the proposed activity will be to investigate these catalysts and to develop related complexes for use in DA and other C-C bond forming reactions. The high efficiency of these catalysts (record low catalyst loading) makes them attractive for various applications in complex molecule synthesis, even for industrial uses. In conjunction with this work, additional heteroatom-substituted dienes will be developed for use in DA reactions. Also presented in the proposal are plans for the development of metal-free catalysts that use hydrogen bonding rather than Lewis acids to promote the enantioselective process. This metal-free acceleration of reactions is not only of fundamental interest, but is also of potential industrial importance, since metal impurities, especially transition metals, are undesirable in precious chemicals such as pharmaceutical drugs. Effort will be directed at the use of hydrogen bonding for the enantioselective catalysis of various C-C bond-forming reactions. The asymmetric catalysis capabilities of numerous chiral alcohols as well as other hydrogen bond donors will be examined. Both of the major subprojects (metal salen complexes and hydrogen bonding catalysis) will integrate crystallographic studies and computational modeling in order to develop models to rationalize the observed enantioselectivities. Overall, the investigations described in this proposal are expected to lead to useful new methodology advances for the asymmetric synthesis of complex molecules. The projects described herein will provide excellent training for undergraduate students, graduate students, and postdoctoral associates in asymmetric catalysis methodology development and complex molecule synthesis, experience that will prepare them well for independent research careers, either in industry or academics.

描述（由申请人提供）：合成高对映体纯度的手性化合物的方法的重要性怎么强调也不为过。 2001年，单一对映体药物占4100亿美元市场总额的36%（1470亿美元）。预计这一数字将稳步增长，到 2008 年，手性药物将构成一个价值超过 2000 亿美元的市场。手性化合物日益增长的经济重要性刺激了许多学术界和工业界实验室的重大研究工作，旨在选择性地制备手性化合物。化合物。 PI 实验室最近的一份报告描述了手性金属 salen 配合物的开发，该配合物是对映选择性 Diels-AIder (DA) 反应的特殊催化剂，DA 反应是有机合成中最有用的反应之一。拟议活动的一个主要重点是研究这些催化剂并开发用于 DA 和其他 C-C 键形成反应的相关配合物。这些催化剂的高效率（创纪录的低催化剂负载量）使其对复杂分子合成的各种应用（甚至工业用途）具有吸引力。结合这项工作，我们将开发更多的杂原子取代的二烯用于 DA 反应。该提案还提出了开发无金属催化剂的计划，该催化剂使用氢键而不是路易斯酸来促进对映选择性过程。这种无金属的反应加速不仅具有根本意义，而且具有潜在的工业重要性，因为金属杂质，特别是过渡金属，在贵重化学品（例如药品）中是不受欢迎的。将致力于利用氢键对各种 C-C 键形成反应进行对映选择性催化。将检查多种手性醇以及其他氢键供体的不对称催化能力。两个主要子项目（金属萨伦配合物和氢键催化）将整合晶体学研究和计算模型，以开发模型来合理化观察到的对映选择性。总体而言，该提案中描述的研究预计将为复杂分子的不对称合成带来有用的新方法学进展。本文描述的项目将为本科生、研究生和博士后提供不对称催化方法开发和复杂分子合成方面的优秀培训，这些经验将为他们在工业界或学术界的独立研究生涯做好准备。